Thank you

This live web event has ended. Thank you for attending.

Description

Precision Medicine:
Exon 20 Marks the Spot
EGFR Exon 20 Insertion Mutations in
Non-Small Cell Lung Cancer (NSCLC)

Why should you register now for this webinar?
Don’t let Exon 20 mutations get by you. Join us to learn about the importance of NGS
testing in identifying EGFR Exon 20 insertion mutations in NSCLC.

Register FREE of charge at http://www.captodayonline.com/062122webinar
In adherence with PhRMA guidelines, spouses or other guests are not permitted to attend company-sponsored programs. For all attendees, please be advised that information such as your name and the value and purpose of any educational item, meal or other items of value you receive may be publicly disclosed. If you are licensed in any state or other jurisdiction, or are an employee or contractor of any organization or governmental entity, that limits or prohibits meals from pharmaceutical companies, please identify yourself so that you (and we) are able to comply with such requirements.
Please note that the company prohibits the offering of gifts, gratuities, or meals to federal government employees/officials. Thank you for your cooperation. This promotional educational activity is not accredited. The program content is developed by Janssen Biotech, Inc. Speakers present on behalf of the company and are required to present information in compliance with FDA requirements for communications about its medicines.
The personal information you provide may be used to contact you about your request to attend the Janssen Biotech, Inc., educational program using your preferred method of communication as indicated by you. This information may be shared with Janssen Biotech, Inc., its affiliates, and a third party for the sole purpose of completing your registration for this program and as required by law.

CAP TODAY does not endorse any of the products or services named within.©Janssen Biotech, Inc. 2022 6/22 cp-199669v2